Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study-Reference-Cited by-同舟云学术

Interstitial lung disease associated with amrubicin chemotherapy in patients with lung cancer: a single institutional study

Published:2016-05-09 Issue:7 Volume:46 Page:674-680
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Jpn. J. Clin. Oncol.

Author:

Miura Yukiko,Saito Yoshinobu,Atsumi Kenichiro,Takeuchi Susumu,Miyanaga Akihiko,Mizutani Hideaki,Minegishi Yuji,Noro Rintaro,Seike Masahiro,Shinobu Kunugi,Kubota Kaoru,Gemma Akihiko

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/46/7/674/7985304/hyw043.pdf

Reference23 articles.

1. Current status of DILD in molecular targeted therapies

2. Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

3. Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study

4. Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group (WJTOG) study

5. Severe Interstitial Lung Disease Associated with Amrubicin Treatment

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Drugs (TS-1, Taxanes, CPT-11, Platinum-Containing Drugs, Etc.);Analysis File of Drug-Induced Lung Injury;2024

2. Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients;Translational Lung Cancer Research;2022-09

3. Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: A systematic review and meta-analysis;Lung Cancer;2021-06

4. Nab-paclitaxel Monotherapy for Relapsed Small Cell Lung Cancer: Retrospective Analysis and Review;Anticancer Research;2020-03

5. Paclitaxel for relapsed small‑cell lung cancer patients with idiopathic interstitial pneumonias;Molecular and Clinical Oncology;2019-03-19